Results from the longest-running trial of semaglutide—the active ingredient in the popular drugs Ozempic and Wegovy—are in, and the verdict is decidedly positive. The study found that people taking semaglutide tended to maintain their initial weight loss for up to four years. Other trial data presented this week also…
The future of weight loss is looking more varied by the second. This week, scientists have reported the preliminary findings of a small trial testing out a novel, non-surgical procedure for obesity—one that works by burning part of the mucus-filled lining of the stomach. The patients in the trial lost about 8% of…
Senator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest generation of effective obesity medications.
In our top science stories this week, reporter Ed Cara explores the similarities and differences between today’s popular obesity drugs and fen-phen, a briefly trendy weight loss aid that was pulled from the market after doctors discovered dangerous side effects. NASA confirmed that a chunk of debris that crashed into…
The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down.
The drug Ozempic, after just a few years on the market, has already become a household name synonymous with weight loss.
The results of a nine-month investigation by health regulators in the European Union should be comforting for anyone taking Ozempic and other similar drugs to treat type 2 diabetes and/or obesity. EU officials said Friday that they failed to find evidence of a causative link between GLP-1 drugs and an increased risk…
Pharmaceutical company Eli Lilly is making a plea to some of its customers: stop hoarding our weight loss drugs. In a new Oscar-themed commercial set to run on TV this weekend, the drugmaker is not-so-subtly telling people to stay away from its new blockbuster medications if they’re only looking to lose a few pounds.…
